These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29398681)

  • 21. Induction and expression of anti-angiogenic vasohibins in the hematopoietic stem/progenitor cell population.
    Naito H; Kidoya H; Sato Y; Takakura N
    J Biochem; 2009 May; 145(5):653-9. PubMed ID: 19179360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasohibin-1 is a new predictor of disease-free survival in operated patients with renal cell carcinoma.
    Kanomata N; Sato Y; Miyaji Y; Nagai A; Moriya T
    J Clin Pathol; 2013 Jul; 66(7):613-9. PubMed ID: 23543668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival.
    Takahashi Y; Saga Y; Koyanagi T; Takei Y; Machida S; Taneichi A; Mizukami H; Sato Y; Matsubara S; Fujiwara H
    Int J Oncol; 2015 Dec; 47(6):2057-63. PubMed ID: 26460696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delta-like 4 and vasohibin 1: two endothelium-produced negative regulators of angiogenesis with distinctive roles.
    Sato Y
    Eur Cytokine Netw; 2009 Dec; 20(4):220-4. PubMed ID: 20167561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasohibin-1 promotes osteoclast differentiation in periodontal disease by stimulating the expression of RANKL in gingival fibroblasts.
    Heo SC; Kim YN; Keum BR; Joo JY; Bae MK; Kim HJ
    Biochim Biophys Acta Mol Basis Dis; 2023 Mar; 1869(3):166632. PubMed ID: 36566872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased vasohibin-1 expression is associated with metastasis and poor prognosis of renal cell carcinoma patients.
    Mikami S; Oya M; Kosaka T; Mizuno R; Miyazaki Y; Sato Y; Okada Y
    Lab Invest; 2017 Jul; 97(7):854-862. PubMed ID: 28287633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasohibin-1 expression in endothelium of tumor blood vessels regulates angiogenesis.
    Hosaka T; Kimura H; Heishi T; Suzuki Y; Miyashita H; Ohta H; Sonoda H; Moriya T; Suzuki S; Kondo T; Sato Y
    Am J Pathol; 2009 Jul; 175(1):430-9. PubMed ID: 19498005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by
    Huang B; Huang M; Li Q
    Technol Cancer Res Treat; 2019; 18():1533033819879905. PubMed ID: 31757187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of mouse alkali burn induced-corneal neovascularization by recombinant adenovirus encoding human vasohibin-1.
    Zhou SY; Xie ZL; Xiao O; Yang XR; Heng BC; Sato Y
    Mol Vis; 2010 Jul; 16():1389-98. PubMed ID: 20680097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced expression of vasohibin-1 is associated with clinicopathological features in renal cell carcinoma.
    Zhao G; Yang Y; Tang Y; Han R; Sun Y
    Med Oncol; 2012 Dec; 29(5):3325-34. PubMed ID: 22865127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VEZF1-guanine quadruplex DNA interaction regulates alternative polyadenylation and detyrosinase activity of VASH1.
    Li L; Williams P; Gao Z; Wang Y
    Nucleic Acids Res; 2020 Dec; 48(21):11994-12003. PubMed ID: 33231681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasohibin: the feedback on a new inhibitor of angiogenesis.
    Kerbel RS
    J Clin Invest; 2004 Oct; 114(7):884-6. PubMed ID: 15467823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma vasohibin-1 and vasohibin-2 are useful biomarkers in patients with esophageal squamous cell carcinoma.
    Yamamoto M; Ozawa S; Ninomiya Y; Koyanagi K; Oguma J; Kazuno A; Hara H; Yatabe K; Kajiwara H; Nakamura N; Sato Y
    Esophagus; 2020 Jul; 17(3):289-297. PubMed ID: 31980976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasohibin-1 suppresses colon cancer.
    Liu S; Han B; Zhang Q; Dou J; Wang F; Lin W; Sun Y; Peng G
    Oncotarget; 2015 Apr; 6(10):7880-98. PubMed ID: 25797264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A potent anti-angiogenic factor, vasohibin-1, ameliorates experimental bronchiolitis obliterans.
    Watanabe T; Okada Y; Hoshikawa Y; Eba S; Notsuda H; Watanabe Y; Ohishi H; Sato Y; Kondo T
    Transplant Proc; 2012 May; 44(4):1155-7. PubMed ID: 22564651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of ELL-associated factor 2 and vasohibin 1 regulating invasion, migration, and angiogenesis in colorectal cancer.
    Feng ML; Sun MJ; Xu BY; Liu MY; Zhang HJ; Wu C
    World J Gastroenterol; 2023 Jun; 29(24):3770-3792. PubMed ID: 37426316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced cancer metastasis in mice deficient in vasohibin-1 gene.
    Ito S; Miyashita H; Suzuki Y; Kobayashi M; Satomi S; Sato Y
    PLoS One; 2013; 8(9):e73931. PubMed ID: 24066086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological Role of Vasohibin in Gastroenterological Cancers: A Meta-Analysis.
    Yamamoto M; Ozawa S; Koyanagi K; Ninomiya Y; Hara H; Kazuno A; Yatabe K; Higuchi T; Nakamura K; Nabeshima K; Sato Y
    Tohoku J Exp Med; 2022 Apr; 256(4):291-301. PubMed ID: 35296570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasohibin-1 and -2 in pulmonary lymphangioleiomyomatosis (LAM) cells associated with angiogenic and prognostic factors.
    Inoue C; Miki Y; Saito-Koyama R; Kobayashi K; Seyama K; Okada Y; Sasano H
    Pathol Res Pract; 2022 Feb; 230():153758. PubMed ID: 35026646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasohibin-1 increases the malignant potential of colorectal cancer and is a biomarker of poor prognosis.
    Kitajima T; Toiyama Y; Tanaka K; Saigusa S; Kobayashi M; Inoue Y; Mohri Y; Kusunoki M
    Anticancer Res; 2014 Oct; 34(10):5321-9. PubMed ID: 25275025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.